Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
Cost considerations also favor micro-dosing for long-term management
Kempuraj et al., 2016a,b
Functional analysis of Arabidopsis mutants points to novel roles for glutathione in coupling H 2 O 2 to activation of salicylic acid accumulation and signaling
Several clinical studies have linked it to improved attention, mental speed, and working memory
3.3 TCMs contribution to the study of predicting high altitude illnesses Traditional Chinese Medicine (TCM), a treasure trove of Chinas traditional medical practice, embodies the profound historical accumulation and wisdom of Chinese civilization
